IN2015DN00585A - - Google Patents

Download PDF

Info

Publication number
IN2015DN00585A
IN2015DN00585A IN585DEN2015A IN2015DN00585A IN 2015DN00585 A IN2015DN00585 A IN 2015DN00585A IN 585DEN2015 A IN585DEN2015 A IN 585DEN2015A IN 2015DN00585 A IN2015DN00585 A IN 2015DN00585A
Authority
IN
India
Prior art keywords
peptide
hexamer
cyclized
avoidance
natural
Prior art date
Application number
Other languages
English (en)
Inventor
Bernhard Fischer
Rudolf Lucas
Hendrik Fischer
Original Assignee
Apeptico Forschung & Entwicklung Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=48672620&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IN2015DN00585(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Apeptico Forschung & Entwicklung Gmbh filed Critical Apeptico Forschung & Entwicklung Gmbh
Publication of IN2015DN00585A publication Critical patent/IN2015DN00585A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/191—Tumor necrosis factors [TNF], e.g. lymphotoxin [LT], i.e. TNF-beta
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
IN585DEN2015 2012-06-28 2013-06-19 IN2015DN00585A (enExample)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP12173983.3A EP2679239A1 (de) 2012-06-28 2012-06-28 Pharmazeutische Zusammensetzung zur Behandlung der durch Sauerstoffarmut und verringerten Luftdruck vermittelten pulmonalen Form der Höhenkrankheit
PCT/EP2013/062777 WO2014001177A1 (de) 2012-06-28 2013-06-19 Pharmazeutische zusammensetzung zur behandlung der durch sauerstoffarmut und verringerten luftdruck vermittelten pulmonalen form der höhenkrankheit

Publications (1)

Publication Number Publication Date
IN2015DN00585A true IN2015DN00585A (enExample) 2015-06-26

Family

ID=48672620

Family Applications (1)

Application Number Title Priority Date Filing Date
IN585DEN2015 IN2015DN00585A (enExample) 2012-06-28 2013-06-19

Country Status (14)

Country Link
US (2) US9802985B2 (enExample)
EP (2) EP2679239A1 (enExample)
JP (1) JP6113277B2 (enExample)
KR (1) KR102010793B1 (enExample)
CN (1) CN104427993B (enExample)
AP (1) AP2014008162A0 (enExample)
AU (1) AU2013283563B2 (enExample)
CA (1) CA2875749C (enExample)
EA (1) EA030384B1 (enExample)
ES (1) ES2602197T3 (enExample)
IN (1) IN2015DN00585A (enExample)
MX (1) MX354302B (enExample)
PE (1) PE20150198A1 (enExample)
WO (1) WO2014001177A1 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015132294A1 (en) * 2014-03-04 2015-09-11 Apeptico Forschung Und Entwicklung Gmbh Attenuation of intrapulmonary inflammation
CA2940351A1 (en) 2014-03-18 2015-09-24 Apeptico Forschung Und Entwicklung Gmbh Dry-powder peptide medicament
JP2018529511A (ja) 2015-08-25 2018-10-11 バル−イラン ユニヴァーシティ 非対称電気化学電池装置およびその作動方法
WO2018211474A1 (en) 2017-05-19 2018-11-22 Trudell Medical International Positive expiratory pressure device
USD874064S1 (en) 2018-05-18 2020-01-28 Trudell Medical International Mask
USD903097S1 (en) 2018-05-18 2020-11-24 Trudell Medical International Mask
USD893806S1 (en) 2018-11-09 2020-08-18 Trudell Medical Internationl Mask and shroud
EP4051311A4 (en) 2019-10-29 2023-12-06 University of Pittsburgh - of the Commonwealth System of Higher Education LUNG-SPECIFIC TARGETING PEPTIDE (LTP), COMPOSITIONS AND RELATED USES
IL294894A (en) 2020-05-08 2022-09-01 Apeptico Forschung & Entwicklung Gmbh A peptide for the prevention or treatment of covid-19
KR20250164550A (ko) 2024-05-16 2025-11-25 장태현 고산병 예방을 위한 입술용 화장료 조성물

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4069819A (en) 1973-04-13 1978-01-24 Societa Farmaceutici S.P.A. Inhalation device
IT1228459B (it) 1989-02-23 1991-06-19 Phidea S R L Inalatore con svuotamento regolare e completo della capsula.
US5891679A (en) 1993-02-03 1999-04-06 N.V. Innogenetics S.A. TNF-alpha muteins and a process for preparing them
HU227661B1 (hu) * 1998-08-14 2011-10-28 Rudolf Lucas Dr TNF-eredetû peptidek ödéma kezelésére
CA2575513C (en) * 2004-08-06 2014-09-16 Altana Pharma Ag Composition comprising a pulmonary surfactant and a tnf-derived peptide
EP2009023A1 (en) 2007-06-04 2008-12-31 Rentschler Beteiligungs GmbH Novel peptides and their use for the treatment of edema
AT506150B1 (de) 2007-12-12 2010-01-15 Apeptico Forschung Und Entwick Zyklisches und cystein-freies peptid
MX2011009251A (es) * 2009-03-04 2011-11-18 Mannkind Corp Sistema mejorado de suministro de farmaco en polvo seco.
AT507953B1 (de) 2009-03-05 2011-02-15 Apeptico Forschung & Entwicklung Gmbh Verfahren zur vermeidung und zur behandlung einer hyperpermeabilität
AT509267A1 (de) * 2010-01-14 2011-07-15 Apeptico Forschung & Entwicklung Gmbh Organische verbindungen zur regulierung von vektoriellen ionenkanälen
AT510585B1 (de) * 2010-11-18 2012-05-15 Apeptico Forschung & Entwicklung Gmbh Zusammensetzung umfassend ein peptid und ein hemmstoff der viralen neuraminidase

Also Published As

Publication number Publication date
JP2015526399A (ja) 2015-09-10
CN104427993A (zh) 2015-03-18
EA201500061A1 (ru) 2015-06-30
US20150225460A1 (en) 2015-08-13
MX2014015048A (es) 2015-06-05
EP2866824B1 (de) 2016-08-10
JP6113277B2 (ja) 2017-04-12
ES2602197T3 (es) 2017-02-20
KR102010793B1 (ko) 2019-08-14
EA030384B1 (ru) 2018-07-31
CA2875749A1 (en) 2014-01-03
MX354302B (es) 2018-02-23
KR20150037815A (ko) 2015-04-08
AU2013283563A1 (en) 2015-01-15
PE20150198A1 (es) 2015-02-19
AP2014008162A0 (en) 2014-12-31
US20190211061A1 (en) 2019-07-11
EP2679239A1 (de) 2014-01-01
US9802985B2 (en) 2017-10-31
WO2014001177A1 (de) 2014-01-03
CN104427993B (zh) 2017-03-08
EP2866824A1 (de) 2015-05-06
CA2875749C (en) 2019-02-26
AU2013283563B2 (en) 2017-06-08

Similar Documents

Publication Publication Date Title
MX354302B (es) Composicion farmaceutica para el tratamiento de la forma pulmonar de mal de montaña por falta de oxigeno y presion de aire reducida.
HK1202800A1 (en) Therapeutic uses of fibroblast growth factor 21 proteins
AU2018260800A1 (en) Hepcidin analogues and uses therof
MX2012009748A (es) USO DE PEPTIDOS INHIBIDORES DEL FACTOR DE CRECIMIENTO TRANSFORMANTE-BETA1(TGF-ß1) PARA EL TRATAMIENTO DE FIBROSIS Y/U OPACIDAD CORNEAL.
WO2015048348A3 (en) Compositions and formulations for increasing renal function and treatment and prevention of renal diseases, and methods of production and use thereof
MX2019011592A (es) Peptidos y analogos de peptidos protectores de los tejidos para evitar y tratar padecimientos y desordenes asociados con daño de los tejidos.
EP4414376A3 (en) Novel depsipeptide and uses thereof
SG10201803862UA (en) Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}acetic acid, compositions, and uses thereof
UA118167C2 (uk) Пептид та його застосування
EP4234698A3 (en) Compositions and methods of use for therapeutic low density lipoprotein-related protein 6 (lrp6) antibodies
WO2014141210A3 (en) Multifunctional immature dental pulp stem cells and therapeutic applications
MX2013004190A (es) Composiciones y metodos para el tratamiento de la hipertension pulmonar.
MX2019013210A (es) Factores de crecimiento recombinantes modificados de fibroblastos y usos terapéuticos de los mismos.
WO2017032856A3 (en) Compounds for inducing tissue formation and uses thereof
EP4653537A3 (en) Rhodopsin gene therapy for regenerating visual function or for preventing deterioration in visual function
SG10201901656WA (en) Nutritional compositions containing a peptide component with adiponectin stimulating properties and uses thereof
WO2013021284A3 (en) Anti-il-6 vaccine composition
WO2015009820A3 (en) Tissue protective peptides and peptide analogs for preventing and treating diseases and disorders associated with tissue damage
IL291543A (en) Medical preparations and their use
NZ732301A (en) Peptide compound, preparation method therefor, and application thereof
WO2011123858A3 (en) Ccn3 peptides and analogs thereof for therapeutic use
WO2012019086A3 (en) Inhibition of lar phosphatase to enhance therapeutic angiogenesis
WO2009158238A3 (en) Fibroblast growth factor (fgf) analogs and uses thereof
EP4219534A3 (en) Methods for treatment of and prophylaxis against inflammatory disorders
MX2015011759A (es) Composiciones nutricionales que contienen un componente peptidico y usos de las mismas.